← Open Payments lookup

BRIAN RESNICK: Open Payments

NPI 1144305012 · TELFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 26 payments from 11 companies in 2025. Trend: 2023 $859 · 2024 $527 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
Novo Nordisk Inc9$205
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$55
AstraZeneca Pharmaceuticals LP3$55
Bayer Healthcare Pharmaceuticals Inc.2$51
Lilly USA, LLC2$40
Boehringer Ingelheim Pharmaceuticals, Inc.2$40
REVANCE THERAPEUTICS, INC.1$22
GlaxoSmithKline, LLC.1$22
ABBVIE INC.1$19
Galderma Laboratories, L.P.1$18

Products named: Rybelsus, XIFAXAN, Kerendia, MOUNJARO, JARDIANCE, AIRSUPRA, Ozempic, DAXXIFY.

Industry payments across PA — which companies pay providers there.